
Jupiter Neurosciences Selected as B2i Digital Featured Company Amid Parkinson's Trial Progress and Longevity Brand Expansion
Jupiter Neurosciences has been selected as a B2i Digital Featured Company, highlighting its dual-path strategy of advancing a Phase IIa Parkinson's disease trial while expanding its Nugevia™ consumer longevity brand, representing a significant inflection point for investor visibility and clinical progress in neuroinflammation treatments.
Read full story
























